Procter & Gamble (NYSE:PG | PG Price Prediction) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk.
The internals tell a different story.
The Crowded Trade Is Quietly Cracking
P&G beat its most recent quarter, but the internals are softening under the polish. Management guided fiscal 2026 results toward the lower end of a $6.83 to $7.09 core EPS range while absorbing a $400 million after-tax tariff headwind and a $100 million commodity hit. Volume has gone quiet in Oral Care, Fabric Care, and Family Care, and the recent top-line gains have leaned on pricing and mix rather than units moving off shelves. That is the exact setup that invites private-label trade-downs when consumer budgets tighten, a risk flagged directly in the organic volume versus pure pricing dynamic going into 2026.
The valuation does not pay you to wait through that. PG trades at a trailing PE of 22 with a 2.85% yield, and shares are down 3.46% over the past year while the broader market has run. This is the crowded mega-cap defensive trade, and the room is full.
The Cash-Flow Powerhouse Already Delivering
Colgate-Palmolive (NYSE:CL) just posted its fourth consecutive EPS beat, delivering adjusted EPS of $0.97 against a $0.9445 consensus, on revenue of $5.324 billion that grew 8.41% year over year. Shares are up 16.06% year to date while PG has lagged. Three reasons this gap widens from here.
1. The cash flow is accelerating. Operating cash flow jumped 24.5% to $747 million in Q1 2026, and free cash flow climbed 27.94% to $609 million. Full-year 2025 generated $3.634 billion in free cash and returned $3.033 billion to shareholders. The 60.6% gross profit margin gives Colgate the cushion to absorb input inflation without crimping earnings power.
2. International volume is doing the heavy lifting. Latin America revenue grew 14.8%, Europe 11.9%, and Asia Pacific 8.9%, with emerging markets posting 6.2% organic growth on 3.5% volume gains. Colgate holds 41.1% of the global toothpaste market and 32.6% of manual toothbrushes. The growth engine runs through international markets, away from the U.S. consumer exposure that weighs on PG.
3. Dividend Aristocrat status with room to run. Colgate is a 63-year Dividend Aristocrat, just lifted the quarterly payout to $0.53, and is executing a Strategic Growth and Productivity Program targeting $200 to $300 million in annual pretax savings. At a $72.5 billion market cap with a forward PE of 23, the runway is wider than the crowded trade above it.
CEO Noel Wallace framed the setup plainly: “We delivered a strong start to 2026, with broad-based top and bottom-line growth. Net sales and organic sales grew in every category and in four of five divisions with a nice balance of volume and pricing growth.”
The Action
Colgate-Palmolive belongs on the short list of defensive holdings worth researching this week.
Top Gaining Stocks
Top Losing Stocks